OEIS (Outpatient Endovascular and Interventional Society) Outcome Data Registry
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 600,000
- 试验地点
- 1
- 主要终点
- Antiplatelet Therapy (ACC/AHA/PAD Coalition)
研究概览
简要总结
This registry is created under the sponsorship of the Outpatient Endovascular and Interventional Society (OEIS) to monitor the clinical course and treatment outcomes of patients undergoing office-based endovascular procedures.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient is 18 years of age or older;
- •Patient is identified as having undergone a percutaneous transluminal vascular intervention or attempted intervention, in an ambulatory (outpatient) facility, for the treatment of peripheral vascular disease within native arteries or bypass grafts, from the infrarenal aorta distally to the feet.
排除标准
- •Patient treated for a non-eligible condition or procedure
- •Diagnostic procedures without intervention or attempted interventions
- •Serious mental illness that might preclude subject's ability to comply with follow up
- •Life expectancy of less than 6 months
结局指标
主要结局
Antiplatelet Therapy (ACC/AHA/PAD Coalition)
时间窗: 30 days
To collect the clinical variables of Patients undergoing endovascular procedures in an outpatient angiograPercentage of patients with PAD that have been prescribed an antiplatelet medication at the reported encounter.
Lipid-Lowering Medications for Patients with PAD
时间窗: 30 days
The rate at which patients with documented peripheral artery disease have documentation of a currently prescribed antihyperlipidemic medication treatment. This may include one of the following: Statin, Bile acid sequestrants, Niacin, Ezetemibe, Fibrates, PCSK9 Inhibitors
Pneumonia Vaccination Status for Older Adults.
时间窗: 30 days
Preventive Care and Screening: Tobacco Use
时间窗: 30 days
Screening and Cessation Intervention. Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user.
Optimal vascular care
时间窗: 30 days
This measure is a composite score of appropriate vascular care measures for treatment of PAD. This measure is a composite result of 1: Antiplatelet Therapy; 2: Preventive Care and Screening: Tobacco Use; and 3: Lipid-Lowering Medications (Statin) for Patients with PAD
Preventive Care and Screening: Influenza Immunization.
时间窗: 30 days
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented.
时间窗: 30 days
Appropriate non-invasive arterial testing for patients with critical limb ischemia who are undergoing a LE peripheral vascular intervention.
时间窗: 30 days
Proportion of patients with non-invasive evaluations present/available prior to LE peripheral vascular interventions in patients with critical limb ischemia.
Appropriate non-invasive arterial testing for patients with intermittent claudication who are undergoing a lower extremity peripheral vascular intervention.
时间窗: 30 days
Proportion of patients with non-invasive evaluations present/available prior to lower extremity peripheral vascular interventions in patients with intermittent claudication.
Emergent transfer from an outpatient, ambulatory surgical center, or office setting.
时间窗: 30 days
Rate of emergent transfer from an outpatient, ASC, or office setting to an acute care facility as a result of an invasive peripheral vascular intervention.
次要结局
未报告次要终点